SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-23-000040
Filing Date
2023-03-23
Accepted
2023-03-23 17:26:42
Documents
5
Effectiveness Date
2023-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_20230323inducement.htm S-8 84898
2 EX-FILING FEES alpn-ex107_20230323inducem.htm EX-FILING FEES 14951
3 EX-5.1 alpn-ex51_20220323induceme.htm EX-5.1 7231
4 EX-23.1 alpn-ex231_20230323inducem.htm EX-23.1 2455
5 image_0.jpg GRAPHIC 74541
  Complete submission text file 0001626199-23-000040.txt   213366
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270806 | Film No.: 23757177
SIC: 2834 Pharmaceutical Preparations